Simplification of the blood stem cell transplantation (BSCT) procedure: large volume apheresis and uncontrolled rate cryopreservation at -80°C
Autor: | Paul Capel, Christophe Ravoet, Etienne Dupont, G Wallef, Geneviève Bastin, F Le Moine, Walter Feremans, Micheline Lambermont, Olivier Pradier, Jean Pierre Delville |
---|---|
Rok vydání: | 2009 |
Předmět: |
Adult
Male medicine.medical_specialty Lymphoma medicine.medical_treatment Urology Antineoplastic Agents Breast Neoplasms Dysgerminoma Transplantation Autologous Disease-Free Survival Neoplasms hemic and lymphatic diseases medicine Humans Multiple myeloma Cryopreservation Chemotherapy Leukemia business.industry Hematopoietic Stem Cell Transplantation Hematology General Medicine Middle Aged Hematopoietic Stem Cells medicine.disease Combined Modality Therapy Chemotherapy regimen Surgery Survival Rate Transplantation Haematopoiesis Apheresis Blood Component Removal Female Multiple Myeloma business |
Zdroj: | European Journal of Haematology. 56:278-282 |
ISSN: | 1600-0609 0902-4441 |
DOI: | 10.1111/j.1600-0609.1996.tb00715.x |
Popis: | Very high-dose chemotherapy with autologous blood stem cell (BSC) rescue becomes more and more widely performed. In order to simplify the technique, a large volume apheresis programme combined with an uncontrolled rate cryopreservation at -80 degrees C was developed. Twenty-six patients suffering from multiple myeloma (n = 8), non-Hodgkin's lymphoma (n = 7), dysgerminoma (n = 4), breast cancer (n = 3), Hodgkin's disease (n = 2), acute lymphoblastic leukaemia (n = 1) and acute myelocytic leukaemia (n = 1) were autografted after a classical high-dose chemotherapy regimen. A single large volume apheresis was sufficient to obtain the threshold value of CD34+ BSC in 24/26 transplantations. The haematological recovery was favourably comparable with the previously published data obtained with controlled rate frozen BSC: median time to granulocytes > 1000/microL and to a self-supporting platelet count > 20,000/microL, respectively, 10.5 and 12 d. The treatment-related mortality was confined to 1/26 BSCT. These results indicate that this easy and cost-saving policy of BSCT is efficacious and safe: sustained long-term haematopoiesis, reduced morbidity and mortality were observed. |
Databáze: | OpenAIRE |
Externí odkaz: |